Generic Name and Formulations:
Antazoline phosphate 0.5%, naphazoline HCl 0.05%; oph. soln; contains benzalkonium chloride.
- Prior Atypical Antipsychotic Use May Increase Mortality Risk in Pneumonia
- Lung Function in Severe Asthma Improved With Benralizumab
- Vitamin D Supplementation Improves Asthma Control
Indications for VASOCON-A:
Temporary relief of ocular redness and itching.
Adults and Children:
<6yrs: not recommended. ≥6yrs: 1–2 drops up to 4 times daily.
Narrow-angle glaucoma. Concurrent MAOIs. Contact lens wear.
Avoid prolonged use. Hypertension. Cardiovascular disease. Urinary hesitancy. Diabetes. Pregnancy. Nursing mothers.
Hypertensive crisis with MAOIs.
Mydriasis, increased IOP, local irritation, allergic dermatitis, sensitization, systemic effects if absorbed, may precipitate narrow-angle glaucoma.